Holocene Advisors, LP Arcutis Biotherapeutics, Inc. Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$5.31 - $10.98 $1.25 Million - $2.59 Million	-235,498 Reduced 16.35%	1,204,538 $6.4 Million
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $4.72 Million - $9.44 Million	-629,141 Reduced 30.41%	1,440,036 $13.7 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $9.45 Million - $15.8 Million	924,034 Added 80.69%	2,069,177 $22.8 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $14 Million - $20.5 Million	1,004,141 Added 712.15%	1,145,143 $16.9 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $2.52 Million - $3.8 Million	141,002 New	141,002 $2.7 Million

172

126M

498K

1.64M

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $560M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.